What is Nanodropper?
Nanodropper is recognized as the sole FDA-listed adaptor designed to reduce the volume of dispensed eyedrops. By attaching this innovative device to standard eyedrop bottles, users can precisely control the drop size, ensuring only the absorbable amount is delivered. This technology aims to enhance patient compliance and reduce medication waste, addressing a critical need in ophthalmic care.
How much funding has Nanodropper raised?
Nanodropper has raised a total of $1.4M across 1 funding round:
Angel/Seed
$1.4M
Angel/Seed (2021): $1.4M with participation from Golden Seeds, Rochester Area Chamber of Commerce, and Alliance of Angels
Key Investors in Nanodropper
Golden Seeds
Golden Seeds is a venture capital firm specializing in start-up, early stage, and growth capital investments, with a presence across multiple US cities.
Rochester Area Chamber of Commerce
The Rochester Area Chamber of Commerce is a membership organization dedicated to promoting business success and advocating for economic issues affecting the local business community.
Alliance of Angels
Alliance of Angels is a leading network of angel investors focused on providing startup funding and seed stage investment to early-stage companies, particularly in technology and life sciences.
What's next for Nanodropper?
The recent major strategic investment signals a pivotal growth phase for Nanodropper. This capital infusion is expected to fuel further product development, expand market reach, and potentially explore new applications for its proprietary drop-reduction technology. The company's trajectory suggests a strong focus on scaling operations and solidifying its position as a leader in ophthalmic device innovation.
See full Nanodropper company page
